# Dime Commercial Bancshares, Inc.: overview

DCOM · NYSE · CIK 846617 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dcom.md) · [Financials](/companies/dcom/financials.md) · [Filings](/companies/dcom/filings.md) · [Insiders](/companies/dcom/insiders.md)

Latest reported revenue: [$6.5m](/filings/0000846617-26-000043.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 31, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000846617-26-000043).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4.3](/filings/0000846617-25-000053.md) | [3.9 d](/filings/0000846617-26-000013.md) | [4.6](/filings/0000846617-26-000030.md) | [4.6](/filings/0000846617-26-000043.md) | [5.2](/filings/0000846617-25-000053.md) | [5.4 d](/filings/0000846617-26-000013.md) | [5.7](/filings/0000846617-26-000030.md) | [6.5](/filings/0000846617-26-000043.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [312.3%](/filings/0000846617-25-000053.md) | [(517.8%) d](/filings/0000846617-26-000013.md) | [462.2%](/filings/0000846617-26-000043.md) | [639.7%](/filings/0000846617-26-000043.md) | [531.2%](/filings/0000846617-25-000053.md) | [588.5% d](/filings/0000846617-26-000013.md) | [603.5%](/filings/0000846617-26-000043.md) | [537.0%](/filings/0000846617-26-000043.md) |
| Diluted EPS | $ per share | [0.29](/filings/0000846617-25-000053.md) | not reported | [0.45](/filings/0000846617-26-000030.md) | [0.64](/filings/0000846617-26-000043.md) | [0.59](/filings/0000846617-25-000053.md) | not reported | [0.75](/filings/0000846617-26-000030.md) | [0.75](/filings/0000846617-26-000043.md) |
| Free cash flow | $m | [(34.1) d](/filings/0000846617-25-000053.md) | not reported | not reported | not reported | [51.2 d](/filings/0000846617-25-000053.md) | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [16.0](/filings/0000846617-24-000018.md) | [16.2](/filings/0000846617-25-000013.md) | [16.4](/filings/0000846617-26-000013.md) | [16.7](/filings/0000846617-26-000013.md) | [19.9](/filings/0000846617-26-000013.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [650.1%](/filings/0000846617-24-000018.md) | [941.4%](/filings/0000846617-25-000013.md) | [584.6%](/filings/0000846617-26-000013.md) | [173.9%](/filings/0000846617-26-000013.md) | [556.0%](/filings/0000846617-26-000013.md) |
| Diluted EPS | $ per share | [2.45](/filings/0000846617-24-000018.md) | [3.73](/filings/0000846617-25-000013.md) | [2.29](/filings/0000846617-26-000013.md) | [0.55](/filings/0000846617-26-000013.md) | [2.36](/filings/0000846617-26-000013.md) |
| Free cash flow | $m | not reported | [291](/filings/0000846617-25-000013.md) | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/dcom/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-28 | [Wu Judy](/insiders/2026271.md) | EVP General Counsel & Corp Sec, Officer | Sale (S) | 887 | $42.33 | $37.5k | [Form 4](/filings/0002026271-26-000004.md) |
| 2026-10-28 | [Perry Joseph](/insiders/1338943.md) | Director | Sale (S) | 3,000 | $16.88 | $50.6k | [Form 4](/filings/0001338943-26-000007.md) |
| 2026-10-26 | [Basswood Capital Management, L.L.C.](/insiders/1085393.md) | Director, Director-by-Deputization | Sale (S) | 5,438 | $43.05 | $234.1k | [Form 4](/filings/0000899140-26-001154.md) |
| 2026-10-26 | [Basswood Capital Management, L.L.C.](/insiders/1085393.md) | Director, Director-by-Deputization | Sale (S) | 101 | $43.05 | $4.3k | [Form 4](/filings/0000899140-26-001154.md) |
| 2026-10-26 | [Basswood Capital Management, L.L.C.](/insiders/1085393.md) | Director, Director-by-Deputization | Sale (S) | 2,165 | $43.05 | $93.2k | [Form 4](/filings/0000899140-26-001154.md) |
| 2026-10-26 | [Basswood Capital Management, L.L.C.](/insiders/1085393.md) | Director, Director-by-Deputization | Sale (S) | 807 | $43.05 | $34.7k | [Form 4](/filings/0000899140-26-001154.md) |
| 2026-10-26 | [Basswood Capital Management, L.L.C.](/insiders/1085393.md) | Director, Director-by-Deputization | Sale (S) | 7,648 | $43.05 | $329.2k | [Form 4](/filings/0000899140-26-001154.md) |
| 2026-10-23 | [Basswood Capital Management, L.L.C.](/insiders/1085393.md) | Director, Director-by-Deputization | Sale (S) | 35,563 | $42.68 | $1.5m | [Form 4](/filings/0000899140-26-001154.md) |
| 2026-10-23 | [Basswood Capital Management, L.L.C.](/insiders/1085393.md) | Director, Director-by-Deputization | Sale (S) | 688 | $42.68 | $29.4k | [Form 4](/filings/0000899140-26-001154.md) |
| 2026-10-23 | [Basswood Capital Management, L.L.C.](/insiders/1085393.md) | Director, Director-by-Deputization | Sale (S) | 14,032 | $42.68 | $598.9k | [Form 4](/filings/0000899140-26-001154.md) |
| 2026-10-23 | [Basswood Capital Management, L.L.C.](/insiders/1085393.md) | Director, Director-by-Deputization | Sale (S) | 8,571 | $42.68 | $365.8k | [Form 4](/filings/0000899140-26-001154.md) |
| 2026-10-23 | [Basswood Capital Management, L.L.C.](/insiders/1085393.md) | Director, Director-by-Deputization | Sale (S) | 31,146 | $42.68 | $1.3m | [Form 4](/filings/0000899140-26-001154.md) |
| 2026-10-22 | [Fegan Michael](/insiders/1767612.md) | Chief Technology & Ops Officer, Officer | Sale (S) | 2,355 | $41.81 | $98.5k | [Form 4](/filings/0001767612-26-000006.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $251.9m | 6,197,711 |  | Added +138,420 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $138.5m | 3,407,671 |  | Reduced −933,522 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $99.0m | 2,434,220 |  | Added +80,434 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $82.7m | 2,035,171 |  | Added +142,612 |
| [BASSWOOD CAPITAL MANAGEMENT, L.L.C.](/funds/1085393.md) | 2026-06-30 | $79.1m | 1,946,016 |  | Reduced −75,288 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $75.0m | 1,844,783 |  | Added +432 |
| [SYSTEMATIC FINANCIAL MANAGEMENT LP](/funds/1085936.md) | 2026-06-30 | $48.3m | 1,188,704 |  | Reduced −21,779 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $42.7m | 1,049,275 |  | Added +451,066 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $42.5m | 1,046,067 |  | Added +19,528 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $34.3m | 842,900 |  | Added +44,109 |

## Recent filings

[All 1,583 filings](/companies/dcom/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 16:34 ET | [10-Q](/filings/0000846617-26-000052.md) | Quarterly report, period 2026-09-30 | 0000846617-26-000052 |
| 2026-10-22 | 16:30 ET | [8-K](/filings/0000846617-26-000049.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000846617-26-000049 |
| 2026-10-20 | 09:00 ET | [8-K](/filings/0001104659-26-117199.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-117199 |
| 2026-10-20 | 06:15 ET | [8-K](/filings/0000846617-26-000047.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000846617-26-000047 |
| 2026-09-24 | 16:30 ET | [8-K](/filings/0000846617-26-000045.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000846617-26-000045 |
| 2026-07-31 | 17:05 ET | [10-Q](/filings/0000846617-26-000043.md) | Quarterly report, period 2026-06-30 | 0000846617-26-000043 |
| 2026-07-23 | 16:31 ET | [8-K](/filings/0000846617-26-000040.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000846617-26-000040 |
| 2026-07-23 | 07:00 ET | [8-K](/filings/0000846617-26-000038.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000846617-26-000038 |
| 2026-06-25 | 16:31 ET | [8-K](/filings/0000846617-26-000036.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000846617-26-000036 |
| 2026-06-01 | 16:02 ET | [8-K](/filings/0000943374-26-000219.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000943374-26-000219 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000846617-26-000013.md), filed Feb 20, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 846617
- Tickers: DCOM, DCBG, DCOM-P
- Exchange: NYSE
- SIC code: 6021 National Commercial Banks
- State of incorporation: NY
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 16:44 ET. No prices; not investment advice.